You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The app would provide step-by-step guidance on how to perform the test and provide positive COVID-19 data to public health officials.
The companies began working together in 2018, when MEDx was known as Qiagen Translational Medicine, on companion and in vitro diagnostics.
The coalition includes partners from all over the world, including universities, research centers, and health systems in South Asia, Africa, South America, and the US.
Concentric by Ginkgo has been partnering with labs across the US in more than 15 states to run testing for schools offering in-person education.
The study will evaluate the emergence of biomarkers that are indicators for autoimmune diseases and assess these biomarkers in mild and moderate COVID-19 patients.
Although the logistics still need to be worked out, the partners hope to streamline oncologists' experience ordering tests that can inform patient care.
CellMax also completed a Series C financing round to speed up development of itsFirstSight liquid biopsy test to detect colorectal cancer and precancer polyps.
Artificial will provide access to its aLab Suite software, which integrates with the Thermo Scientific Momentum Workflow software and robotics hardware.
The firms plan to build a workflow for CTC isolation directly from a patient's bloodstream for single-cell downstream molecular analysis such as sequencing, genotyping, or digital PCR.
Mologic will help develop and manufacture Aptamer's AptaDx SARS-CoV-2 test, which is designed to detect the spike protein antigen of the virus.